《即日市評》恆指本週累跌749點 內險股及平安好醫生今受壓
受保險及科網股拖累下,港股今日持續向下。美股道指昨升0.7%,標普500及納指創收市高,但蘋果及亞馬遜公佈業績遜預期;執筆之時美國十年期國債孳息率升至1.616釐,美匯指數跌至93.5,美股道指期貨最新跌84點或0.23%,納指期貨最新跌0.8%。人行今開展2,000億人幣7天期逆回購操作(連續五日開展2,000億人民幣逆回購),單日淨投放1,000億人幣,上證綜指全日升28點或0.8%收3,547點、深證成指漲1.45%,內地創業板指數升2.2%,滬深兩市成交額共1.1萬億人民幣。
恆指今早低開88點,早段跌幅曾擴大至241點見25,314點,其後跌幅曾收窄至39點見25,516點,全日跌178或0.7%,收25,377點;國指跌90點或1%,收8,961點;恆生科技指數跌69點或1.08%,收6,375點。大市全日成交總額1,262.66億元,滬、深港通南下交易分別淨流入15.7億及4億元人民幣。啤酒股有支持,百威亞太(01876.HK)股價續升3.9%。
恆指本週累跌749點或2.9%、國指本週累395跌點或4.2%、恆生科指本週累跌378點或5.6%。美債孳息回落影響週期性股份及市場關注內地新冠疫情反覆,將利淡經濟活動表現。恆指本月累升801點或3.3%、國指本月累升235點或2.7%、恆生科指本月累升274點或4.5%。
【內險股持續跌 平安好醫生挫】
內險股持續受壓,中國平安(02318.HK)全日股價跌4.2%收55.9元,國壽(02628.HK)股價下滑3.1%。摩根大通指中資保險股壽險業務面臨挑戰,國壽旗下保險代理今年以來下跌29%,料重整相關業務仍是主要挑戰。瑞銀指,國壽首三季新業務價值按年跌20%,意味第三季跌幅爲21%,勝該行預期,相信下跌原因主要仍是經紀數目減少及市場競爭激烈,料有關負面因素將於近期維持。
衛健委近日諮詢互聯網診療監管、倡公開收費標準,平安好醫生(01833.HK)股價急跌14.9%,阿裏健康(00241.HK)股價下滑3.2。中金髮表報告指,預計隨着線上覆診行爲流程的監管落地,行業中部分不規範的線上問診行爲或將在短期內解決,並對處方藥銷售的增量業務的放量節奏有一定程度負面影響,而對具備完善合規監管體系,完備診療購藥流程手段的頭部公司,集中度長期或將進一步提升。
【沽空率回落 比亞迪電子弱】
港股今日市寬改善,主板股票的升跌比率爲20比19(上日爲13比27);恆指成份股今日25只股份上升,下跌股份33只,升跌比率爲42比55(上日爲43比55);大市今日錄沽空172.47億元,佔可沽空股份成交1,048.51億元的16.449%(上日17.352%)
比亞迪電子(00285.HK)全日股價挫10.3%收23.15元。瑞信發表報告表示,比亞迪電子今年第三季業績表現令人失望,收入爲210億元人民幣,佔該行及場同業對甚今年下半年預測各35%及37%,第三季純利爲5.14億人民幣,僅佔該行對其今年下半年預測的40%。該行指,比亞迪電子盈利較低主因芯片短缺及電力短缺,該行下調對公司2021至2023年盈利預期分別16%、8%及5%。(wl/a)
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.